What alternative regimens would you consider to neoadjuvant TCHP in setting of national carboplatin shortage for locally advanced HER2+ breast cancer?

In TRAIN-2, hospitals were allowed to use split dose carboplatin AUC 3 on days 1, 8 for 9 q3wk cycles and the pCR rates and outcomes were the same as the FEC treated group. That could be an option if you are getting limited carbo resupply on a regular basis. WSG ADAPT THP looked good for ER-HER2+ di...